Lyellpharma news
Sep 03, 2020
Amylyx’s neuron-protecting drug slows ALS decline; Antisense drugs could help fight ALS and dementia; CAR-T research updates; Orca and Lyell announces research partnership
Amylyx's neuron-protecting drug slows ALS decline in the late-phase study A novel combination of compounds has displayed that it can help decrease amyotrophic lateral sclerosis (ALS) by supporting the brain's neurons' inner workings. After six months of treatment, AMX0035 of Amylyx Pharmaceuticals demonstrate...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
